Antituberculosis medication as a possible epigenetic factor of Leber's hereditary optic neuropathy
- 1 May 2010
- journal article
- case report
- Published by Wiley in Clinical & Experimental Ophthalmology
- Vol. 38 (4) , 363-366
Abstract
Purpose: To investigate if antituberculosis medication including ethambutol could be a possible epigenetic factor in visual loss in Leber's hereditary optic neuropathy (LHON).Methods: The authors reviewed the medical records of 46 patients registered at Bundang Seoul National University Hospital from 2002 to 2006, who developed the typical clinical neuro‐ophthalmologic features of LHON and possessed a mtDNA mutation at nucleotide 11778, 14484, 3460 or 4171.Results: Three of the 46 patients developed visual loss while taking antituberculosis medication. These three patients had the mtDNA 11778 mutation with a mean age of 32.7 years at the onset of visual loss, whereas the mean age of other 43 patients was 21.2 years. One of these three patients was female.Conclusion: Antituberculosis medication may be an epigenetic factor of LHON in patients with a primary LHON mutation. This risk should be recognized by physicians and LHON carriers.Keywords
This publication has 13 references indexed in Scilit:
- A New Color Vision Test to Differentiate Congenital and Acquired Color Vision DefectsOphthalmology, 2007
- Leber's Hereditary Optic Neuropathy Precipitated by EthambutolJapanese Journal of Ophthalmology, 2006
- Leber′s hereditary optic neuropathy masquerading as ethambutol- Induced optic neuropathy in a young maleIndian Journal Of Ophthalmology, 2006
- Extensive investigation of a large Brazilian pedigree of 11778/haplogroup J Leber hereditary optic neuropathyAmerican Journal of Ophthalmology, 2003
- Leber's hereditary optic neuropathy triggered by antiretroviral therapy for human immunodeficiency virusEye, 2003
- Spectrum of the mitochondrial DNA mutations of Leber's hereditary optic neuropathy in KoreansJournal of Neurology, 2003
- Mitochondrial DNA C4171A/ND1 is a novel primary causative mutation of Leber's hereditary optic neuropathy with a good prognosisAnnals of Neurology, 2002
- Metabolic optic neuropathiesSeminars in Ophthalmology, 2002
- Optic neuropathy after treatment with anti-tuberculous drugs in a subject with Leber's hereditary optic neuropathy mutationJournal of Neurology, 2001
- Ethambutol-Induced Vacuolar Changes and Neuronal Loss in Rat Retinal Cell Culture: Mediation by Endogenous ZincToxicology and Applied Pharmacology, 2000